Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
High steady-state column density of I((2)P3/2) atoms from I2 photodissociation at 532 nm: Towards parity non-conservation measurements.

Scientific reports

Katsoprinakis GE, Chatzidrosos G, Kypriotakis JA, Stratakis E, Rakitzis TP.
PMID: 27629914
Sci Rep. 2016 Sep 15;6:33261. doi: 10.1038/srep33261.

Steady-state column densities of 10(17) cm(-2) of I((2)P3/2) atoms are produced from photodissociation of I2 vapour at 290.5 K using 5 W of 532 nm laser light. Recombination of the I((2)P3/2) atoms at the cell walls is minimized by...

Cite
Katsoprinakis GE, Chatzidrosos G, Kypriotakis JA, et al. High steady-state column density of I((2)P3/2) atoms from I2 photodissociation at 532 nm: Towards parity non-conservation measurements. Sci Rep. 2016;6:33261doi: 10.1038/srep33261.
Katsoprinakis, G. E., Chatzidrosos, G., Kypriotakis, J. A., Stratakis, E., & Rakitzis, T. P. (2016). High steady-state column density of I((2)P3/2) atoms from I2 photodissociation at 532 nm: Towards parity non-conservation measurements. Scientific reports, 633261. https://doi.org/10.1038/srep33261
Katsoprinakis, G E, et al. "High steady-state column density of I((2)P3/2) atoms from I2 photodissociation at 532 nm: Towards parity non-conservation measurements." Scientific reports vol. 6 (2016): 33261. doi: https://doi.org/10.1038/srep33261
Katsoprinakis GE, Chatzidrosos G, Kypriotakis JA, Stratakis E, Rakitzis TP. High steady-state column density of I((2)P3/2) atoms from I2 photodissociation at 532 nm: Towards parity non-conservation measurements. Sci Rep. 2016 Sep 15;6:33261. doi: 10.1038/srep33261. PMID: 27629914; PMCID: PMC5024090.
Copy Download .nbib Format: NLM
Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder.

Alcoholism, clinical and experimental research

Robinson JD, Cui Y, Karam-Hage M, Kypriotakis G, Versace F, Ait-Daoud Tiouririne N, Anthenelli RM, Cinciripini PM.
PMID: 35037278
Alcohol Clin Exp Res. 2022 Jan 17; doi: 10.1111/acer.14771. Epub 2022 Jan 17.

BACKGROUND: There is preliminary evidence that the anticonvulsant topiramate increases the likelihood of both smoking and alcohol abstinence among smokers with alcohol use disorder (AUD), but its therapeutic mechanism has not been determined. We used event-related potentials (ERPs) to...

Cite
Robinson JD, Cui Y, Karam-Hage M, et al. Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder. Alcohol Clin Exp Res. 2022;doi: 10.1111/acer.14771.
Robinson, J. D., Cui, Y., Karam-Hage, M., Kypriotakis, G., Versace, F., Ait-Daoud Tiouririne, N., Anthenelli, R. M., & Cinciripini, P. M. (2022). Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder. Alcoholism, clinical and experimental research, . https://doi.org/10.1111/acer.14771
Robinson, Jason D, et al. "Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder." Alcoholism, clinical and experimental research vol. (2022). doi: https://doi.org/10.1111/acer.14771
Robinson JD, Cui Y, Karam-Hage M, Kypriotakis G, Versace F, Ait-Daoud Tiouririne N, Anthenelli RM, Cinciripini PM. Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder. Alcohol Clin Exp Res. 2022 Jan 17; doi: 10.1111/acer.14771. Epub 2022 Jan 17. PMID: 35037278.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries